HealthcareUS health authority says Moderna vaccine effective in under-fives

US health authority says Moderna vaccine effective in under-fives

Credit: Pixabay/CC0 Public Domain

US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its COVID-19 vaccine among very young children were accurate, ahead of a decision next week on whether to authorize two inoculations against the virus in kids aged six months to five years.

The Food and Drug Administration (FDA), which independently analyzed from conducted by Moderna, said against symptomatic cases of COVID-19 was 51 percent in babies aged six months to less than two years old, and 37 percent in children aged two to five years.

The figures are lower than those recorded during clinical trials on adults, but that is only because the trials for the very were conducted during a wave linked to the Omicron variant, according to the FDA.

“Although the VE (vaccine efficacy) … in children six months to five years is lower than that observed in the pivotal adult or older pediatric studies, it is highly consistent with real-world vaccine effectiveness observed against Omicron in adults,” the FDA said in a statement.

Even though Moderna’s vaccine has proven less effective against the Omicron variant, it remains very good at protecting against severe cases of the disease, the FDA pointed out.

That is why the FDA concluded that the Moderna data “support the administration” of the vaccine in two doses of 100 micrograms each in adolescents aged 12 to 17, 50 micrograms for six to 11 year olds, and 25 micrograms in children aged six months to five years.

In the United States, Moderna’s vaccine is currently only authorized for people aged 18 and older.

The latest document, stretching to more than 100 pages and published by the US agency, will serve as a basis for the authorization discussions next week.

An advisory committee of experts must meet over two days to study the request for authorization of the vaccine, as well as that of Pfizer, and make its recommendation.

The FDA is expected to publish its independent analysis of data from Pfizer early next week.

Pfizer has filed an application for authorization for children aged six months to four years, although its vaccine will be administered in three doses.

Pfizer asks FDA to OK COVID-19 vaccine for under 5s

© 2022 AFP

US health authority says Moderna vaccine effective in under-fives (2022, June 10)
retrieved 10 June 2022

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Original Source Link


Please enter your comment!
Please enter your name here

Latest News

Beyond the Byline: Venture capital firms lure health system CEOs

What are the consequences for these health systems if they do not have a completed succession plan? Alex Kacik:...

Vogue on KBJ and ACB

The September issue of Vogue Magazine is a big deal. In the past, the publisher would boast of...

Oort cloud comets may spin themselves to death

Comets from the solar system’s deep freezer often don’t survive their first encounter with the sun. Now one...

Mortgage Demand Falls To New 22-Year Low As Housing Market Fuels Recession Fears

Topline Despite falling mortgage rates providing some relief to potential home buyers, mortgage applications fell to the lowest level...

Christina Hall’s Daughter Taylor Is Growing Up Fast – Look!

Where did the time go!? That’s what Christina Hall is wondering after going on a shopping trip with her...

Must Read

CalDigit TS4 review: king of the Thunderbolt docks

Once the domain of IT departments...

Parents cut back on children’s pocket money as UK inflation bites

Children are feeling the effect of the UK’s...
- Advertisement -

You might also likeRELATED
Recommended to you